Stock Scheduled Dividends 08/31/2018
08/30/2018 AECLY AE
Stock Scheduled Dividends 08/31/2018
08/30/2018 AECLY AE & CI Ltd. American Depository Receipts Grey Market Cash Dividend 0.0706
08/30/2018 AFAP AFA Protective Systems, Inc. Common Stock Pink No Information Cash Dividend 0.50
08/30/2018 AGRIP Agribank FCB Preferred Stock Grey Market Cash Dividend 1.7188
08/30/2018 ATDRY Auto Trader Group Plc. American Depository Receipts Pink Current Cash Dividend 0.01066
08/30/2018 BSDGY Bosideng International Holdings Ltd. American Depository Receipts Pink Current Cash Dividend 0.3323
08/30/2018 BWEL Boswell (J.G.) Co. Common Stock Pink No Information Cash Dividend 3.75
08/30/2018 CESDF CES Energy Solutions Corp. Ordinary Shares Pink Current Cash Dividend 0.005
08/30/2018 CFIGY Challenger Ltd. American Depository Receipts Pink Current Cash Dividend 1.26472
08/30/2018 CKHUY CK Hutchison Holdings LTD American Depository Receipts Pink Current Cash Dividend 0.09083
08/30/2018 CLPHY CLP Holdings Ltd. American Depository Receipts Pink Current Cash Dividend 0.06222
08/30/2018 CMGMY Chemring Group Plc. American Depository Receipts Pink Current Cash Dividend 0.01285
08/30/2018 CNAF Commercial National Financial Corp. Common Stock OTCQX U.S. Premier Cash Dividend 0.26
08/30/2018 CPKF Chesapeake Financial Shares, Inc. Common Stock OTCQB Cash Dividend 0.14
08/30/2018 CTGSP Connecticut Natural Gas Corp. Preferred Stock Pink No Information Cash Dividend 0.0625
08/30/2018 EFRTF Nexus Real Estate Investment Trust Other Security Type Grey Market Cash Dividend 0.01333
08/30/2018 EKTAY Elekta AB American Depository Receipts Pink Current Cash Dividend 0.05368
08/30/2018 ELMTY Elementis Plc American Depository Receipts Pink Current Cash Dividend 0.10341
08/30/2018 EMYB Embassy Bancorp Inc. Common Stock OTCQX U.S. Premier Cash Dividend 0.17
08/30/2018 FBAK First National Bank Alaska (Anchorage) Common Stock Pink Current Cash Dividend 3.20
08/30/2018 FBPI First Bancorp of Indiana, Inc. Common Stock Pink Current Cash Dividend 0.155
08/30/2018 FFWC FFW Corporation Common Stock Pink Current Cash Dividend 0.21
08/30/2018 FREVS First Real Estate Investment Trust of New Jersey Fund Pink Current Cash Dividend 0.05
08/30/2018 FSUGY Fortescue Metals Group Ltd American Depository Receipts OTCQX International Premier Cash Dividend 0.15532
08/30/2018 FXNC First National Corp. Common Stock Pink Current Cash Dividend 0.05
08/30/2018 GABK Grand Bank Corp. Common Stock Pink Current Cash Dividend 25.00
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Storm Brewing Over Madrigal Pharmaceuticals Well, folks, here we are smack dab in the middle of another roller-coaster ride in the biotech sector, and it ain't pretty. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is in hot water with some serious allegations thrown their way. The company is now under investigation by Kessler Topaz Meltzer & Check, LLP, a top-notch...
Continue Reading
Change is afoot in the world of beauty. No Makeup Makeup, a brand that's managed to carve out a sizable niche, recently bid farewell to two of its main architects: Kim Wileman and Shauna Lahiri. These women didn't just steer the ship; they built the damn thing. Kicking Off the No Makeup Revolution Wileman and Lahiri were the pistons firing away at No Makeup Makeup, a...
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...
Continue Reading
DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...
Continue Reading
The air's thick with tension for investors of Blue Owl Technology Finance Corp. (NYSE:OTF) as they wake up to the news of a securities class action lawsuit that's no small fry. You don’t have to look too far to see why the folks holding the bag might be steamed. We’re talking about a 44% drop in stock price since the merger with Blue Owl Technology Finance Corp....
Continue Reading
Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...
Continue Reading
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...
Continue Reading
Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...
Continue Reading
Top 5 Most Recently Viewed Articles
UGO Token Launching on PancakeSwap UGO, the latest addition to the innovative ecosystem featuring Gooo and WeGo, is set to make waves in the trading sphere with its exceptional Hybrid Token Model. This new framework emphasizes fairness, sustainability, and real-world utility, offering an exciting opportunity for both everyday traders and crypto enthusiasts alike. What...
Continue Reading
California Labor Law Clashes in the Spotlight When a lawsuit against a big name like Empyrean Anaheim Resort hits headlines, it raises eyebrows. Folks, we're talking about a class action filed in California, no less—a state with some of the toughest labor laws around. The legal eagles at Blumenthal Nordrehaug Bhowmik De Blouw LLP are on the case, claiming Empyrean...
Continue Reading
China's Role in Mediating Middle Eastern Conflicts As the world’s second-largest oil consumer, China is stepping into a critical role by urging Israel and Iran to de-escalate their ongoing tensions. In this complex geopolitical landscape, China's top diplomat, Wang Yi, took proactive measures through separate phone calls with officials from both nations, advocating for...
Continue Reading
Jason Wyatt Recognized for His Exceptional Leadership In a remarkable acknowledgment by The Inner Circle, Jason Wyatt, an esteemed CEO, is honored as an Inner Circle Lifetime member. This recognition is a testament to his significant contributions to Transforming Leadership and Driving Success Through Innovative Coaching. Jason Wyatt's Innovative Approach to Leadership As...
Continue Reading
Terray Therapeutics Secures Significant Series B Investment Terray Therapeutics, a dynamic player in the biotechnology sector, has successfully closed an oversubscribed Series B funding round, raising $120 million. This investment aims to advance the company's unique generative AI pipeline for small molecule therapeutics, enhancing their capabilities to bring innovative...
Continue Reading